Triple-negative breast cancer is a highly aggressive and heterogeneous type of breast cancer (BC) that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.